Scarica l'app Stockscreener
4.35
3.33%
-0.15
Dopo l'orario di chiusura:
4.39
0.04
+0.92%
Precedente Chiudi:
$4.50
Aprire:
$4.5
Volume 24 ore:
94,561
Relative Volume:
0.14
Capitalizzazione di mercato:
$155.94M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-9.19%
1M Prestazione:
-19.44%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.20
$4.50
Intervallo di 1 settimana:
$4.19
$4.80
Portata 52W:
$3.85
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
Nome
Bioage Labs Inc
Settore
Telefono
510-806-1445
Indirizzo
1445A SOUTH 50TH STREET, RICHMOND
Confronta BIOA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
4.35 | 155.94M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-09 | Downgrade | Jefferies | Buy → Hold |
| 2024-10-21 | Iniziato | Citigroup | Buy |
| 2024-10-21 | Iniziato | Jefferies | Buy |
| 2024-10-21 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioage Labs Inc Borsa (BIOA) Ultime notizie
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
2025-02-24 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - TradingView
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman - GlobeNewswire
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA - Stockhouse Publishing
Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
2025-02-24 | Investors who Lost Money on BioAge Labs, Inc.(BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-24 | BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
The Gross Law Firm Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
BIOA Deadline: BIOA Investors with Losses in Excess of $100K Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire
Class Action Filed Against BioAge Labs, Inc. (BIOA)March 10, 2025 Deadline to JoinContact Levi & Korsinsky - Stockhouse Publishing
BIOA IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
BIOA IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – BIOA - GlobeNewswire Inc.
2025-02-23 | BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA CLASS ACTION DEADLINE: BioAge Labs Investors with - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline - Stockhouse Publishing
BioAge Labs, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations – - GlobeNewswire
2025-02-21 | Levi & Korsinsky Notifies Shareholders of BioAge Labs, Inc. (BIOA) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioAge Labs, Inc.(BIOA) Shareholders - Morningstar
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference - The Manila Times
BioAge Labs, Inc. (BIOA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire
2025-02-20 | BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-20 | Shareholders of BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact The Gross Law Firm about pending Class ActionBIOA - PR Newswire
Lost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse Publishing
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - GlobeNewswire
2025-02-19 | BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-18 | BioAge Labs, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff ... - The Bakersfield Californian
BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. - GlobeNewswire
Kirby McInerney LLP Urges Investors in BioAge Labs, Inc. (BIOA) to Inquire About Their Rights in Class Action Lawsuit - Business Wire
BIOA Deadline Approaching on March 10, 2025: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Class Action Lawsuit Deadline | FinancialContent Business Page - Financial Content
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming DeadlinesBIOA - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit – BIOA - GlobeNewswire
2025-02-18 | BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Deadline Alert: Join Class Action Lawsuit Against BIOA by March 10, 2025 – Contact Levi & Korsinsky - The Octant
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before ... - The Bakersfield Californian
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, - GlobeNewswire
BioAge Labs Inc (BIOA) gets rating Downgrade from Morgan Stanley - Knox Daily
2025-02-17 | BioAge Labs, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your RightsBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. - Financial Content
2025-02-16 | Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
2025-02-16 | Shareholders that Lost Money on BioAge Labs, Inc. (BIOA) Should Contact Levi & Korsinsky About Pending Class ActionBIOA | NDAQ:BIOA | Press Release - Stockhouse Publishing
Bioage Labs Inc Azioni (BIOA) Dati Finanziari
Non sono disponibili dati finanziari per Bioage Labs Inc (BIOA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.92%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):